Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Euphrasia for Post-LPI Inflammation
NCT02416128Withdrawn
- Sponsor
- Larkin Community Hospital
- Start
- Apr 2015
- Primary completion
- Mar 2016
- Modality
- Herbal Medicine, Dietary Supplement, Homeopathic remedy
01
Overview
Randomised, double-blind trial of euphrasia in post-operative inflammation (2 arms), sponsored by Larkin Community Hospital. Primary endpoint: Anti-inflammatory efficacy. Planned start Apr 2015; status: withdrawn.
02
Drugs
euphrasia
03
Conditions
post-operative inflammation
Beyond the preview
Go deeper on NCT02416128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02416128.